Blood Tests for HIV Assessment
The primary test for HIV assessment is the conventional serum test consisting of a repeatedly reactive immunoassay followed by confirmatory Western blot or immunofluorescent assay, which has sensitivity and specificity greater than 99.5%. 1
Primary Screening Tests
Fourth-Generation Combination Tests (Recommended First-Line)
- Combination antigen/antibody assays that simultaneously detect:
- HIV antibodies (anti-HIV-1 and anti-HIV-2)
- HIV p24 antigen 1
- These tests significantly reduce the diagnostic window period compared to antibody-only tests 2
- Available as:
- Instrument-based laboratory assays (preferred for routine screening)
- Rapid point-of-care tests (though these have lower sensitivity for p24 antigen) 3
Alternative Screening Options
- Rapid HIV testing using blood or oral fluid specimens
- Results available in 5-40 minutes
- Sensitivity and specificity >99.5%
- Important: Initial positive results require confirmation with conventional methods 1
- Qualitative HIV-1 RNA testing
- Particularly useful in suspected acute infection when antibodies may not yet be detectable 1
Confirmatory Testing
For any reactive screening test, confirmation is essential:
- Western blot or immunofluorescent assay - traditional confirmatory method 1
- HIV viral load (HIV RNA) testing - recommended before ART initiation due to possibility of false-positive screening results 1
Special Situations
Suspected Acute HIV Infection
- HIV RNA testing or combination antibody + p24 antigen tests are essential for:
- Persons with ongoing condomless sexual exposures
- Those sharing needles or works
- Individuals with signs/symptoms of acute HIV infection 1
- HIV RNA testing is more sensitive during the acute phase before antibody development 1
Baseline Testing After Diagnosis
After confirming HIV infection, additional tests should be ordered:
- HIV genotype to assess transmitted NRTI and NNRTI resistance 1
- CD4 cell count to assess immune status 1
- HIV viral load to establish baseline viral activity 1
Screening Frequency Recommendations
- All persons who have ever been sexually active: at least once in their lifetime 1
- High-risk individuals (MSM, transgender women, people who inject drugs): at least annually, and as frequently as every 3 months 1
- Pregnant women: during each pregnancy 1
Common Pitfalls to Avoid
False negatives during window period: Fourth-generation tests can detect infection approximately 4.9 days after a positive PCR result, but there's still a window period when tests may be negative 2
False positives: All HIV tests can have false-positive results, which is why confirmatory testing is essential before initiating treatment 1
Relying solely on antibody tests: Using antibody-only tests may miss acute infections when p24 antigen or HIV RNA would be detectable 3
Inadequate follow-up testing: For high-risk individuals with negative results, regular retesting is essential as risk for HIV often changes over a person's lifetime 1
By using the appropriate HIV testing strategy based on clinical context and risk factors, clinicians can ensure timely diagnosis, which is critical for reducing morbidity, mortality, and preventing further transmission.